Steve Kelly and the other panelists discuss their paper titled “Assessing the policy and access environment across European countries for SMA patients.”
For more information on this event, click here.
An analysis of the effect of drug pricing provisions in the Build Back Better Act on pharmaceutical innovation
Charles River Associates has previously assessed the implications of proposals to implement international reference pricing in the US and found they would...